Although there is evidence that consumption of a high glucosinolate diet is linked with reduced incidence of chronic diseases, future large-scale placebo-controlled human trials including standardized glucosinolate supplements are needed
This is now recapitulated in the placenta, where our study suggests that chronic inflammation in the placenta leads to a decline in NAD + availability and mitochondrial dysfunction
However, it was not able to halt the progression of the disease, as both infants passed away before reaching six months of age [74]
Elucidation of the molecular mechanisms underlying sorafenib-induced hepatotoxicity
Moreover, it should be noted that, specifically, glutathione does not have any health claims authorised by the EFSA (European Union) or by the FDA (United States)
10.1016/j.phytochem.2021.112854 74 ShenD.ZhangL.LiS.TangL